MENTAL DISORDERS

Clinical trials for MENTAL DISORDERS explained in plain language.

Never miss a new study

Get alerted when new MENTAL DISORDERS trials appear

Sign up with your email to follow new studies for MENTAL DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 4 Not yet finished but already full! 8 Completed 7 Terminated 1

Alzheimer's drug extension trial halted early — what we know

Disease control Terminated

This study gave Alzheimer's patients who had already completed earlier XPro1595 trials an extra 55 to 74 weeks of the drug to check long-term safety and effects on memory and brain health. Only 11 people took part, and the trial was terminated early, so the findings are limited. …

Matched conditions: MENTAL DISORDERS

Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

MENTAL DISORDERS

Get alerted when new MENTAL DISORDERS trials appear

Alzheimer's drug extension trial halted early — what we know